immatics biotechnologies ... (IMTXW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.03
-0.02 (-40.00%)
At close: Jan 14, 2025, 3:58 PM
0.05
60.00%
After-hours Jan 14, 2025, 07:49 PM EST
undefined% (undefined)
Bid | 0.04 |
Market Cap | 460.48M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0 |
PE Ratio (ttm) | n/a |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.06 |
Volume | 51,484 |
Avg. Volume (20D) | 0 |
Open | 0.05 |
Previous Close | 0.05 |
Day's Range | 0.03 - 0.06 |
52-Week Range | 0.03 - 0.06 |
Beta | undefined |
About IMTXW
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 2, 2020
Employees 542
Stock Exchange NASDAQ
Ticker Symbol IMTXW
Website https://www.immatics.com